The Editor's Roundtable: Chronic Stable Angina Pectoris

American Journal of Cardiology

Volumn 100, Issue 11, 2007, Pages 1635-1643

  Friedewald, Vincent E ^a   King III, Spencer B ^b   Pepine, Carl J ^c   Vetrovec, George W ^d   Roberts, William C ^e  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; NITRATE; PROPRANOLOL; RANOLAZINE; VERAPAMIL;

ACUTE HEART INFARCTION; ARTERIAL PRESSURE; ARTERY STEAL SYNDROME; ARTICLE; ATHEROSCLEROSIS; CLINICAL FEATURE; CONTINUING EDUCATION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY RECANALIZATION; DEPRESSION; DIASTOLE; DIASTOLIC BLOOD PRESSURE; DRUG INDICATION; EXERCISE; FATIGUE; HIGH RISK PATIENT; HUMAN; NIGHTMARE; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; SIDE EFFECT; SINUS BRADYCARDIA; STABLE ANGINA PECTORIS; SYNDROME X; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION;

EID: 36348930351     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.09.001     Document Type: Note

References (12)

1. Rosamund W., Flegal K., Friday G., Furie K., Go A., Greenland K., Haase N., Ho M., Howard V., Kissela B., and American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2007 update: a report from the American Heart Associations Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 (2007) e69-e171
2. Prinzmetal M., Kennamer R., and Merliss R. A variant form of angina pectoris. Am J Med 27 (1959) 375-388
3. Boden W.E., O'Rourke R.A., Teo K.K., Hartigan P.M., Maron D.J., Kostuk W.J., Knudtson M., Dada M., Casperson P., Harris C.L., Chaitman B.R., Shaw L., Gosselin G., Nawaz S., Title L.S., Gau G., Blaustein A.S., Booth D.C., Bates E.R., Spertus J.A., Berman D.S., Mancini J., Weintraub W.S., and COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356 (2007) 1503-1516
4. Pepine C.J. Does the brain know when the heart is ischemic?. Ann Intern Med 124 (1996) 1006-1008
5. Chan A.T., Manson J.E., Feskanich D., Stampfer M.J., Colditz G.A., and Fuchs C.S. Long-term aspirin use and mortality in women. Arch Intern Med 167 (2007) 562-572
6. Loscalzo J. Folate and nitrate-induced endothelial dysfunction. Circulation 104 (2001) 1086-1088
7. Poole-Wilson P.A., Swedberg K., Cleland J.G., Di Lenarda A., Hanrath P.M.D., Komajda M., Lubsen J., Lutiger B., Metra M., Remme W.J., Torp-Pedersen C., Scherhag A., Skene A., and COMET Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET). Lancet 362 (2003) 7-13
8. Chaitman B.R., Skettino S.L., Parker J.O., Hanley P., Meluzin J., Kuch J., Pepine C.J., Wang W., Nelson J.J., Hebert D.A., Wolff A.A., and MARISA Investigators. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. J Am Coll Cardiol 43 (2004) 1375-1382
9. Chaitman B.R., Pepine C.J., Parker J.O., Skopal J., Chumakova G., Kuch J., Wang W., Skettino S.L., and Wolff A.A. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. JAMA 291 (2004) 309-316
10. Morrow D.A., Scirica B.M., Karwatowska-Prokopczuk E., Murphy S.A., Budaj A., Varshavsky S., Wolff A.A., Skene A., McCabe C.H., Braunwald E., and MERLIN-TIMI 36 Trial Investigators. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes. JAMA 297 (2007) 1775-1783
11. Van den Brand M.J.B.M., Rensing B.J.W.M., Morel M.-aM., Foley D.P., de Valk V., Breeman A., Suryapranata H., Haalebos M.M.P., Wijns W., Wellens F., Balcon R., Magee P., Ribeiro E., Buffolo E., Unger F., and Serruys P.W. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol 39 (2002) 559-564
12. Mann G.V., Spoerry A., Gary M., and Jarashow D. Atherosclerosis in the Masai. Am J Epidemiol 95 (1972) 26-37